Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 9.00
+0.30 (3.45%)
Oct 9, 2026, 5:29 PM CET
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 2.53 billion as of October 9, 2026. It is the 19,519th most valuable company in the world and the 237th biggest in Sweden. Its market cap has decreased by 16.15% in one year.
Market Cap
2.53B
Enterprise Value
1.63B
Revenue
3.99M
Global Rank
Country Rank
#237 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 2.53B, an increase of 2,785.26%. That is a compound annual growth rate of 36.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.53B | -20.35% |
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 4.53B |
| Hansa Biopharma AB | 3.45B |
| BioInvent International AB | 1.52B |
| Flerie AB | 1.34B |
| Genovis AB (publ.) | 1.33B |
| Saniona AB | 1.23B |
| Infant Bacterial Therapeutics AB | 980.72M |
| AlzeCure Pharma AB | 965.28M |